JP2022529806A5 - - Google Patents

Info

Publication number
JP2022529806A5
JP2022529806A5 JP2021562811A JP2021562811A JP2022529806A5 JP 2022529806 A5 JP2022529806 A5 JP 2022529806A5 JP 2021562811 A JP2021562811 A JP 2021562811A JP 2021562811 A JP2021562811 A JP 2021562811A JP 2022529806 A5 JP2022529806 A5 JP 2022529806A5
Authority
JP
Japan
Prior art keywords
same
compound according
different
groups
item
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021562811A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022529806A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/029066 external-priority patent/WO2020219417A1/en
Publication of JP2022529806A publication Critical patent/JP2022529806A/ja
Publication of JP2022529806A5 publication Critical patent/JP2022529806A5/ja
Pending legal-status Critical Current

Links

JP2021562811A 2019-04-24 2020-04-21 E-セレクチン、ガレクチン-3、および/またはcxcr4ケモカイン受容体のガラクトース連結型多量体糖模倣性阻害剤 Pending JP2022529806A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962838206P 2019-04-24 2019-04-24
US62/838,206 2019-04-24
PCT/US2020/029066 WO2020219417A1 (en) 2019-04-24 2020-04-21 Galactose-linked multimeric glycomimetic inhibitors of e-selectins, galectin-3, and/or cxcr4 chemokine receptors

Publications (2)

Publication Number Publication Date
JP2022529806A JP2022529806A (ja) 2022-06-24
JP2022529806A5 true JP2022529806A5 (cg-RX-API-DMAC7.html) 2023-04-24

Family

ID=70680623

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021562811A Pending JP2022529806A (ja) 2019-04-24 2020-04-21 E-セレクチン、ガレクチン-3、および/またはcxcr4ケモカイン受容体のガラクトース連結型多量体糖模倣性阻害剤

Country Status (9)

Country Link
US (1) US20230079833A1 (cg-RX-API-DMAC7.html)
EP (1) EP3958978A1 (cg-RX-API-DMAC7.html)
JP (1) JP2022529806A (cg-RX-API-DMAC7.html)
KR (1) KR20220012246A (cg-RX-API-DMAC7.html)
CN (1) CN114340736A (cg-RX-API-DMAC7.html)
AU (1) AU2020263266A1 (cg-RX-API-DMAC7.html)
BR (1) BR112021021244A2 (cg-RX-API-DMAC7.html)
CA (1) CA3136661A1 (cg-RX-API-DMAC7.html)
WO (1) WO2020219417A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7547345B2 (ja) 2018-12-27 2024-09-09 グリコミメティクス, インコーポレイテッド ガレクチン-3阻害性c-グリコシド
ES3063748T3 (en) * 2019-07-31 2026-04-20 Crescent Biopharma Inc E-selectin antagonists for use in enhancing the survival of reconstituted, bone marrow-depleted hosts
US20230147312A1 (en) 2020-03-27 2023-05-11 Glycomimetics, Inc. Treatment of acute respiratory distress syndrome and related conditions with antagonists of e-selectin
WO2021247396A1 (en) 2020-05-31 2021-12-09 Magnani John L Compounds and methods for reduction of cancer cell burden and protection of normal hematopoiesis
JP2023529485A (ja) 2020-06-14 2023-07-10 グリコミメティクス, インコーポレイテッド E-セレクチン標的化を介して微小環境媒介耐性を克服するための組成物および方法
WO2023014690A1 (en) 2021-08-03 2023-02-09 Glycomimetics, Inc. Compositions and methods for overcoming microenvironment-mediated resistance via e-selectin targeting

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5183010B2 (ja) 2002-05-16 2013-04-17 グリコミメティクス, インコーポレイテッド セレクチンによって媒介される機能を阻害するための化合物および方法
SE0401300D0 (sv) 2004-05-21 2004-05-21 Forskarpatent I Syd Ab Novel Galactoside Inhibitors of Galectins
SI2264043T1 (en) 2005-09-02 2018-01-31 Glycomimetics, Inc. HETEROBIFUNCTIONAL PAN-SELECTINE INHIBITORS
US7964569B2 (en) 2006-10-12 2011-06-21 Glycomimetics, Inc. Glycomimetic replacements for hexoses and N-acetyl hexosamines
US8697862B2 (en) 2008-05-16 2014-04-15 Galecto Biotech Ab Synthesis of galactoside inhibitors
EP2794626B3 (en) 2011-12-22 2020-08-05 GlycoMimetics, Inc. E-selectin antagonist compounds
CA2888527A1 (en) * 2012-10-31 2014-05-08 Glycomimetics, Inc. E-selectin antagonists compounds and methods of use
CN107108679B (zh) 2014-12-03 2020-10-23 糖模拟物有限公司 E-选择蛋白和cxcr4趋化因子受体的异双官能抑制剂
BR112019006642A2 (pt) * 2016-10-07 2019-07-02 Glycomimetics Inc antagonistas multiméricos de e-selectina altamente potentes

Similar Documents

Publication Publication Date Title
JP2020510054A5 (cg-RX-API-DMAC7.html)
JP2021527125A5 (cg-RX-API-DMAC7.html)
JP2024050527A5 (cg-RX-API-DMAC7.html)
JP2021088610A5 (cg-RX-API-DMAC7.html)
JP2024504932A5 (cg-RX-API-DMAC7.html)
JP2019518766A5 (cg-RX-API-DMAC7.html)
JP2019529518A5 (cg-RX-API-DMAC7.html)
RU2020115095A (ru) Пиридиновые, пиразиновые и триазиновые соединения в качестве аллостерических ингибиторов shp2
JP2022544714A5 (cg-RX-API-DMAC7.html)
RU2013156074A (ru) Диазакарбазолы и способы применения
JP2024512154A5 (cg-RX-API-DMAC7.html)
JP2020528889A5 (cg-RX-API-DMAC7.html)
JP2019504898A5 (cg-RX-API-DMAC7.html)
JP2021523159A5 (cg-RX-API-DMAC7.html)
JP2012532112A5 (cg-RX-API-DMAC7.html)
JP2021100969A (ja) Ep4アンタゴニスト
JP2017500334A5 (cg-RX-API-DMAC7.html)
JP2017536395A5 (cg-RX-API-DMAC7.html)
JP2022533069A5 (cg-RX-API-DMAC7.html)
JP2009524691A5 (cg-RX-API-DMAC7.html)
JP2021529814A5 (cg-RX-API-DMAC7.html)
JP2016515096A5 (cg-RX-API-DMAC7.html)
JP2005505506A5 (cg-RX-API-DMAC7.html)
JP2003529537A5 (cg-RX-API-DMAC7.html)
JP2023527025A5 (cg-RX-API-DMAC7.html)